Metoprolol vs. Ramipril

See how Metoprolol and Ramipril compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Metoprolol is a beta-blocker that also treats angina and heart failure, while ramipril is an ACE inhibitor mainly used for blood pressure and cardiovascular risk reduction.

  • Both come as once-daily oral options, but metoprolol needs a slow taper when stopping while ramipril usually does not.

  • Metoprolol's most common side effects involve heart rate and blood pressure changes, while ramipril's most common side effect is a persistent dry cough.

Metoprolol vs. Ramipril Drug Summary

Metoprolol

Metoprolol succinate is a beta-1 selective beta-blocker used to treat high blood pressure, angina, and stable heart failure. It comes as an extended-release tablet taken once a day, starting at a low dose and increasing over several weeks. It works by slowing the heart rate and reducing the force of each heartbeat.

Ramipril

Ramipril is an ACE inhibitor used to lower blood pressure, reduce cardiovascular risk in high-risk patients, and treat heart failure after a heart attack. It is taken as a capsule once or twice a day, starting at a low dose and increasing based on blood pressure response. It works by relaxing blood vessels by blocking the enzyme that produces angiotensin II.

Metoprolol vs. Ramipril Side Effects

Metoprolol

Most common
Hypotension (up to 27.4%)
Bradycardia (up to 15.9%)
Dizziness (about 10%)
Tiredness (about 10%)

Ramipril

Most common
Headache (up to 5.4%)
Cough (up to 3%)
Dizziness (up to 2.2%)
Fatigue (up to 2.0%)

Metoprolol vs. Ramipril Dosage

Metoprolol

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 12.5 mg once daily Weeks 1-2
Maximum dose 100 mg once daily Week 5 onward
Dose changes 3 increases Every 2 weeks

Ramipril

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2.5 mg once daily Week 1
Maximum dose Up to 20 mg once daily If needed
Dose changes 3 increases Every week

Metoprolol vs. Ramipril Indications

Metoprolol

Metoprolol succinate is FDA-approved for hypertension, angina, and stable heart failure (NYHA Class II-IV). Doctors also prescribe it off-label for atrial fibrillation rate control, migraine prevention, and essential tremor.

  • Hypertension (to lower blood pressure)

  • Angina pectoris (chest pain)

  • Stable heart failure (NYHA Class II-IV)

  • Off-label: atrial fibrillation rate control

Ramipril

Ramipril is FDA-approved for hypertension, to reduce the risk of heart attack, stroke, or cardiovascular death in high-risk patients 55 and older, and for heart failure that develops after a heart attack. It is not approved to treat angina.

  • Hypertension (to lower blood pressure)

  • Cardiovascular risk reduction (age 55+, high risk)

  • Heart failure after a heart attack

  • Often combined with a thiazide diuretic

Metoprolol vs. Ramipril Pros and Cons

Metoprolol

Metoprolol has a broader FDA label, covering angina and heart failure in addition to hypertension, and decades of real-world use back its safety profile. It must be tapered gradually when stopping, and it carries beta-blocker-specific risks like bradycardia and masked hypoglycemia symptoms.

Pros

  • Also FDA-approved for angina and heart failure

  • Once-daily extended-release tablet

  • Decades of clinical use and established safety data

  • Available off-label for migraine and tremor control

Cons

  • Must be tapered slowly, never stopped abruptly

  • Contraindicated in bradycardia and certain heart blocks

  • Can cause fatigue and depression as class effects

  • May mask symptoms of low blood sugar in diabetics

Ramipril

Ramipril is one of the best-studied ACE inhibitors for cardiovascular risk reduction, including in patients without diagnosed hypertension. Its main drawbacks are a class-wide dry cough and pregnancy risks that require stopping the drug immediately if pregnancy occurs.

Pros

  • FDA-approved to cut cardiovascular risk even without hypertension

  • Can typically be stopped without a slow taper

  • Does not commonly cause bradycardia or mask low blood sugar

  • Well-studied in large outcome trials like HOPE and AIRE

Cons

  • Class-wide risk of persistent dry cough

  • Contraindicated in pregnancy; must stop immediately if pregnant

  • Risk of angioedema, especially with the first dose

  • Only approved for heart failure after a heart attack, not general heart failure

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.